Travere Therapeutics (TVTX) Selling, General & Administrative (2011 - 2026)
Powered by 
Analysis
Travere Therapeutics (TVTX) Selling, General & Administrative (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 582.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 662.10 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -417.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 216.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 110.21 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 593.21 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 347.92 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 161.89 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 247.47 Mn |
| 10 | Travere Therapeutics | 6.11 Bn | 6.11 Bn | 162.52 Mn | 96.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 96.11 Mn |
| Mar 31, 2026 | 80.25 Mn |
| Dec 31, 2025 | 101.69 Mn |
| Sep 30, 2025 | 86.45 Mn |
| Jun 30, 2025 | 62.58 Mn |
| Mar 31, 2025 | 60.41 Mn |
| Dec 31, 2024 | 69.50 Mn |
| Sep 30, 2024 | 65.62 Mn |
| Jun 30, 2024 | 64.78 Mn |
| Mar 31, 2024 | 64.22 Mn |
| Dec 31, 2023 | 63.59 Mn |
| Sep 30, 2023 | 67.80 Mn |
| Jun 30, 2023 | 68.20 Mn |
| Mar 31, 2023 | 65.95 Mn |
| Dec 31, 2022 | 57.09 Mn |
| Sep 30, 2022 | 52.42 Mn |
| Jun 30, 2022 | 52.98 Mn |
| Mar 31, 2022 | 46.79 Mn |
| Dec 31, 2021 | 18.48 Mn |
| Sep 30, 2021 | 36.07 Mn |